纳豆激酶基因的克隆与表达

利用ＰＣＲ方法从分泌纳豆激酶的枯草杆菌基因组ＤＮＡ 中扩增得到了纳豆激酶基因,并测定其核苷酸序列．利用基因重组技术构建了纳豆激酶基因的表达载体,并在大肠杆菌中进行了表达．ＳＤＳ－聚丙烯酰胺凝胶电泳表明,表达蛋白占菌体蛋白的１５．２％ ,琼脂糖－纤维蛋白平板法测出表达产物具有溶解血栓活性．     

纳豆激酶基因的克隆及其在毕赤酵母中的表达

纳豆激酶纳是从日本传统食品纳豆中发现的一类具有溶栓效果的蛋白酶,由于其具有安全,高效,作用时间长,易吸收,廉价等优点,现在正成为一个开发治疗血栓类疾病药物的研究热点。从本实验室保存的一株高溶栓的纳豆杆菌N07出发,提取总基因组DNA,利用PCR手段扩增获得了纳豆激酶长为825bp的成熟肽基因片段。构建重组表达质粒pPICZaA-NK,经EcoR I、Xba I双酶切、PCR、测序验证得出重组表达质粒上的外源基因即为825bp的目的片段;将重组质粒pPICZaA-NK用内切酶Sac I线性化后电击导入毕赤酵母X33,通过含Zeocin的YPDS平板筛选获得重组酵母。重组酵母在BMMY培养基中发酵培养,用1%甲醇诱导目的蛋白表达。用纤维蛋白平板法检测发现发酵上清具有纤溶活性,经硫酸铵盐析、透析、Sephadex-G50过柱等步骤分离得到纳豆激酶蛋白,进行SDS-PAGE鉴定表明,表达的纳豆激酶蛋白分子量为27KD。以尿激酶为标准,实验所得纳豆激酶发酵上清液溶栓活性约为195U/mL。成功的将纳豆激酶成熟肽基因在毕赤酵母X33中表达,为纳豆激酶基因工程进一步研究奠定基础。     

纳豆激酶的原核表达、纯化及其特性分析（英文）

纳豆激酶(Nattokinase)作为一种新型溶解血栓的纤维蛋白溶解酶,有着广阔的市场前景和巨大的产业化潜力。本研究从枯草芽胞杆菌(Bacillus subtilis natto)发酵液中提取、纯化纳豆激酶,依次通过硫酸铵盐析、凝胶过滤层析和疏水层析方法纯化纳豆激酶,纯化倍数为5.2,纯化率为46.3%。纯化后的纳豆激酶经SDS-PAGE电泳显示相对分子量约为28 kD a,纤维蛋白平板法显示活性为4 580 IU/mg。但纳豆激酶在枯草芽胞杆菌发酵液中的含量较低,因此在原核表达载体大肠埃希菌(Escherichia coli)BL21(DE3)中克隆并高效表达了纳豆激酶基因,其纳豆激酶产量显著提高,但酶活相对降低。     

纳豆激酶基因工程研究进展

纳豆激酶是由纳豆芽孢杆菌(Bacillussubtillisnatto)分泌的一种具有纤溶作用的碱性丝氨酸蛋白酶。对纳豆激酶基因的克隆与表达,基因与蛋白质结构以及基因工程纳豆激酶的特性和功能进行了综述。     

纳豆激酶基因在大肠杆菌中的表达及活性分析

目的:构建纳豆激酶基因的表达载体,鉴定其在大肠杆菌中的表达及表达产物的生物活性鉴定.方法:以纳豆芽胞杆菌基因组为模板,PCR技术克隆出纳豆激酶基因的成熟肽序列,分别克隆进具有信号肽的pMAL-p2x及无信号肽pMAL-c2x质粒中,经酶切和测序鉴定其正确性,分别将重组质粒转化至大肠杆菌中表达.结果:成功构建的两组重组质粒在IPTG诱导下,均能分别在37℃及16℃条件下表达出可溶性的融合蛋白,SDS-PAGE胶检测证实重组质粒在大肠杆菌中可表达出相对分子量约76kDa的纳豆激酶蛋白.纤维蛋白平板实验证明两种融合蛋白均有活性,且有信号肽的融合蛋白的酶活较无信号肽的融合蛋白高.结果:成功构建了两组重组纳豆激酶基因的表达质粒,且该两组重组基因在大肠杆菌中可溶性表达并具有生物活性,因此为下一步研究表达产物纳豆激酶的功能、应用和生产奠定了基础.     

纳豆激酶酶原基因和纳豆激酶基因的克隆及在大肠杆菌中表达

目的：构建可高效生产有活性的纳豆激酶的大肠杆菌工程菌。方法：将纳豆激酶酶原（pro-nattokinase,pro-NK)基因和纳豆激酶（natokinase,NK)基因,并分别克隆到表达融合蛋白的高效表达载体pJN上,构建出表达质粒pJNK1和pJNK2,并转化大肠杆菌BL21（DE3）。结果：IPTG诱导下,两个融合蛋白的表达量均达到30%,活性检测显示表达纳豆激酶酶原融合蛋白的菌株pJNK-1(BL)诱导后菌体破碎上清的溶栓活性比表达纳豆激酶融合蛋白的菌株pJNK-2(BL)高2-3倍,结论：纳豆激酶酶原融合蛋白部分自减切产生纳豆激酶成熟肽。     

纳豆激酶基因在E.coli HB101中的初步表达研究

利用PCR技术以纳豆杆菌染色体DNA为模板扩增纳豆激酶基因,将该基因克隆到温度诱导型表达形体pVB220上,转化E．coliHB101,获得转豆激酶基因重组菌。在确定了其最佳培养时间与诱导时间后,SDS－PAGE分析结果表明基因表达产物为分泌型,蛋白表达量占菌体蛋白的12％左右,液体发酵后纳豆激酶产量可达120U／ml菌液,对重组菌中重组质粒的稳定性进行研究,结果表明该质粒在宿主菌中具有良好的分离稳定性,而结构稳定性较差。     

纳豆芽孢杆菌菌种纯化及不同氮源对其产纳豆激酶的影响

纳豆激酶(nattokinase, NK)是一种由纳豆芽孢杆菌发酵产生的丝氨酸蛋白酶,具有良好的纤溶活性。本研究从wako Nattokinase中分离纯化出高品质的纳豆芽孢杆菌,旨在探究最适宜该菌产纳豆激酶的发酵培养基氮源。研究人员选择了6种氮源对其进行发酵实验,通过连续测定发酵液的菌量、pH和纤溶活性以观察不同氮源对纳豆芽孢杆菌产纳豆激酶的影响。研究结果表明:最优氮源为乳清蛋白,在以此为氮源的培养基中发酵培养120 h后,纳豆激酶的纤溶活性高达1 757.79 U/mL。以乳清蛋白发酵培养基对纳豆芽孢杆菌进行发酵,不仅可以得到高活性的纳豆激酶,还可为纳豆激酶应用于食品、保健品领域提供思路。     

具有抗HIV活性的天花粉蛋白在大肠杆菌中的表达及纯化

目的:天花粉蛋白(TCS)有较强的抗HIV活性。利用基因工程技术在大肠杆菌中表达TCS并进行纯化。方法:从新鲜栝楼叶片中获取TCS基因组DNA,利用PCR技术扩增其全长基因,经BamHⅠ和EcoRⅠ双酶切后与原核表达载体pRSET-A连接,转化感受态E.coliDH5α,提取质粒进行酶切鉴定及测序;将所获阳性重组质粒转化感受态E.coliBL21(DE3)得到工程菌,经IPTG诱导表达后,对表达产物进行SDS-PAGE及Western印迹鉴定;用Ni-NTA柱对所获目的蛋白进行纯化。结果:获得了目的蛋白的可溶性高效表达,并通过了Western印迹鉴定。经Ni-NTA柱纯化后,得到大量均一的6His-TCS融合蛋白。结论:TCS在大肠杆菌中的表达与纯化,为通过基因工程方法研制具有抗HIV活性的药物奠定了基础。     

纳豆激酶基因在E.coli HB101中的初步表达研究*

利用PCR技术以纳豆杆菌染色体DNA为模板扩增纳豆激酶基因 ,将该基因克隆到温度诱导型表达载体pBV2 2 0上 ,转化_{E .coli}HB1 0 1 ,获得转纳豆激酶基因重组菌。在确定了其最佳培养时间与诱导时间后 ,SDS PAGE分析结果表明基因表达产物为分泌型 ,蛋白表达量占菌体蛋白的12%左右 ,液体发酵后纳豆激酶产量可达 120U/mL菌液。对重组菌中重组质粒的稳定性进行研究 ,结果表明该质粒在宿主菌中具有良好的分离稳定性 ,而结构稳定性较差。     

纳豆激酶基因的克隆及其在枯草杆菌中的表达

为研究纳豆激酶（nattokinase,NK)的生物化学性质,以纳豆芽胞杆菌基因组DNA为模板,PCR扩增包含启动子及3‘端非翻译区的纳豆激酶全长基因序列。经鉴定后构建大肠杆菌－枯草杆菌穿梭表达质粒pBLNK,转化蛋白缺陷型枯草杆菌,筛选表达菌株。表达株培养15h后收集培养上清液,SDS－PAGE分析证实表达产物后,用超滤浓缩、分子筛、离子交换等步骤分离纯化重组NK,每升发酵液得纯度达95％的重组NK约100mg,比活性达12000u/mg。     

Purification of nattokinase by reverse micelles extraction from fermentation broth: effect of temperature and phase volume ratio

Nattokinase is a novel fibrinolytic enzyme that is considered to be a promising agent for thrombosis therapy. In this study, reverse micelles extraction was applied to purify and concentrate nattokinase from fermentation broth. The effects of temperature and phase volume ratio used for the forward and backward extraction on the extraction process were examined. The optimal temperature for forward and backward extraction were 25°C and 35°C respectively. Nattokinase became more thermosensitive during reverse micelles extraction. And it could be enriched in the stripping phase eight times during backward extraction. It was found that nattokinase could be purified by AOT reverse micelles with up to 80% activity recovery and with a purification factor of 3.9.     

Purification and characterization of the dnaA46 gene product

The alleles of dnaA46, dnaA5, and dnaA204 have been cloned from the Escherichia coli chromosome into a protein-overproducing vector. Under conditions of induced expression, similar amounts of dnaA46 and dnaA5 gene products and less of the dnaA204 gene product were observed. Facilitated by elevated expression levels, an improved method for purification of dnaA+ protein and the purification of dnaA46 protein have been obtained. The replication activity of dnaA46 protein did not appear to be thermolabile upon prior incubation at various temperatures. Thermolabile replication activity was observed under conditions of coupled DNA synthesis. In contrast with the wild type protein, DNA synthesis dependent on dnaA46 protein showed a pronounced lag before incorporation of deoxyribonucleotides.     

人精氨酸酶在毕赤酵母的高效表达、纯化和活性研究

目的：人精氨酸酶（Arginase, Arg）的基因arg在毕赤酵母高效分泌表达,建立相应纯化工艺路线,研究重组人精氨酸酶的活性。方法：将人精氨酸酶基因arg按正确的阅读框架插入到毕赤酵母表达载体pPIC9α信号肽基因后,构建得到重组毕赤酵母表达质粒。转化毕赤酵母GS115筛选高表达菌株。结果：成功构建了酵母表达载体pPIC-Arg,转化毕赤酵母GS115后筛选到分泌表达目的蛋白Arg的菌株,目标蛋白可以分泌到培养基中。经过膜过滤和凝胶过滤层析对培养基上清进行纯化,即可获得纯度达到95%的活性产物。活性测定表明,纯化的Arg比活性为310 IU/mg。结论：成功构建了Arg的毕赤酵母高效表达菌种,建立了目标物质的分离纯化工艺。     

尿酸氧化酶在大肠杆菌中的表达、纯化及活性鉴定

尿酸氧化酶(urate oxidase,Uricase,EC.1.7.3.3)是一种能将尿酸氧化为尿囊素的蛋白酶。合成黄曲霉(Aspergillus flavus)尿酸氧化酶基因,构建表达载体pET43.1a/uox,重组质粒经双酶切鉴定和序列分析,证明插入序列正确,转化到大肠杆菌(Escherichia coli)JM109,菌株经诱导表达尿酸氧化酶蛋白,目的蛋白经过超声破碎,经检测以可溶性蛋白为主;菌体经超声破碎后,上清经过阴离子柱和阳离子柱两步纯化,得到尿酸氧化酶纯品,纯品以分光光度法进行体外酶活性测定。结果显示:尿酸氧化酶在大肠杆菌中获得高效表达,目的蛋白占菌体总蛋白的50%;表达产物经过两步层析柱纯化,获得电泳扫描纯度为95%的纯品;在体外活性测定中具有分解尿酸的能力,在临床检测和治疗中有重要意义。     

Characterisation of mutagenised acid-resistant alpha-amylase expressed in <Emphasis Type="Italic">Bacillus subtilis</Emphasis> WB600

Based on the original thermostable alpha-amylase gene from Bacillus licheniformis, two amino acids were site-directed mutagenised by polymerase chain reaction to obtain a new gene. This gene, with Leu134→Arg and Ser320→Ala, was substituted for acid-resistant capability previously. To favor purification of the product, high-level expression and secretion of mature, authentic and stable recombinant mutagenised alpha-amylase were achieved with protease-deficient strain Bacillus subtilis WB600 as the host. The recombinant mutagenised alpha-amylase with the activity of 4,700 U/mL was then purified by ammonium sulphate fractionation, anion exchange and gel filtration, consecutively. By multi-step purification, the specific activity of the recombinant protein was up to 916.7 U/mg with a 187.1-fold purification. The mutagenised protein was found to be more acid resistant than the native protein. The optimum pH and stable range of pH with the mutagenised protein was 4.5 and 4.0 to 6.5, respectively, compared with pH 6.5 and 5.5 to 7.0 as the favorite pH and pH stability range of the native protein.     

Microbial production of nattokinase: current progress,challenge and prospect

Nattokinase (EC 3.4.21.62) is a profibrinolytic serine protease with a potent fibrin-degrading activity, and it has been produced by many host strains. Compared to other fibrinolytic enzymes (urokinase, t-PA and streprokinase), nattokinase shows the advantages of having no side effects, low cost and long life-time, and it has the potential to be used as a drug for treating cardiovascular disease and served as a functional food additive. In this review, we focused on screening of producing strains, genetic engineering, fermentation process optimization for microbial nattokinase production, and the extraction and purification of nattokinase were also discussed in this particular chapter. The selection of optimal nattokinase producing strain was the crucial starting element for improvement of nattokinase production. Genetic engineering, protein engineering, fermentation optimization and process control have been proved to be the effective strategies for enhancement of nattokinase production. Also, extraction and purification of nattokinase are critical for the quality evaluation of nattokinase. Finally, the prospect of microbial nattokinase production was also discussed regarding the recent progress, challenge, and trends in this field.     

枯草杆菌DC-2纳豆激酶基因的克隆及其融合蛋白在E.coli中的表达

纳豆激酶是一种纤维蛋白溶解酶 ,有望开发成为新型的溶栓药物 .从中国豆豉中分离的具有较强纤溶活性的枯草杆菌DC 2中提取总DNA ,根据纳豆激酶 (NK)基因序列设计引物 ,用PCR法扩增NK基因 .序列分析表明 ,NK基因成熟肽编码区含有 82 5bp ,编码 2 75个氨基酸残基 ,与文献报道的序列分别有 93 4 %和 94 5 %同源性 .将NK基因插入载体pGEX 4T1构建表达质粒pGEX NK ,转化大肠杆菌JM10 9后 ,经 1mmol LIPTG诱导 4h ,发现大量NK融合蛋白表达 ,并形成包涵体 .SDS PAGE分析表明 ,NK融合蛋白作为包涵体的分子量为 5 3kD .凝胶自动扫描结果显示 ,NK融合蛋白约占菌体可溶性蛋白的 2 6 % .